Alterity Therapeutics up big on advancement of ATH434 for Parkinsonian disorder [Seeking Alpha]
Alterity Therapeutics Limited - American Depositary Shares (ATHE)
Company Research
Source: Seeking Alpha
Alterity Therapeutics (NASDAQ:ATHE71%receivingAlterity reached agreement with the agency on the non-clinical investigations required to support the mid-stage study, along with patient population, safety monitoring plan, and strategy for evaluating drug exposure during the trial.The agency and Alterity will work together to develop an endpoint that is best suited for the MSA patients.The company is also pursuing approvals in Europe and Australia.
Show less
Read more
Impact Snapshot
Event Time:
ATHE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATHE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATHE alerts
High impacting Alterity Therapeutics Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ATHE
News
- Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive RefundGlobeNewswire
- Alterity Therapeutics Limited (NASDAQ: ATHE) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $4.00 price target on the stock.MarketBeat
- Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual MeetingGlobeNewswire
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review [Yahoo! Finance]Yahoo! Finance